Risperdal Product Description
Risperdal is a selective monoaminergic antagonist, belongs to a class of pharmacological antipsychotic drugs (neuroleptics). Risperdal demonstrates a high level of safety and tolerability, and can be administered to both adults and pediatric patients.
- Neuroleptic Risperdal is prescribed to children and adolescents (aged 5 to 17 years) for short-term treatment (up to 6 weeks) of aggression and irritability associated with autistic disorder.
- Risperdal can be administered for treatment of schizophrenia and related psychotic disorders to teenagers aged from 13 to 17 years.
- Risperdal can be indicated for treatment of acute bipolar mania, schizophrenia, and related psychoses to adults and elderly patients, as well as to control aggression or psychotic symptoms in dementia related to Alzheimer's disease.
For treatment of schizophrenia and bipolar mania in adults, an effective dose of Risperdal varies from 1 to 16 mg per day. For treatment of schizophrenia and irritability in autistic disorder in adolescents and children, an effective dose of Risperdal varies from 0.5 mg to 6 mg a day.
If you remembered that you had missed a dose of Risperdal, take it as soon as possible. If it is near the time for the next prescribed dose of this antipsychotic agent, just skip the missed tablet of Risperdal and continue to use the medicine as usual.
For treatment of schizophrenia and manic episodes in bipolar disorder in older patients, the recommended initial dose of Risperdal is 0.5 mg twice a day. Since there is no sufficient clinical data of the antipsychotic drug use in elderly patients, extra caution is recommended in this age group.
Risperdal tablets are recommended to be stored at room temperature not above 25°C. Keep antipsychotic agent Risperdal in an original container in a dry warm place, out of reach of children.
Risperdal Safety Information
Long-term application of Risperdal may cause tardive dyskinesia (involuntary, repetitive body movements). To reduce the risk of development of this neurological disorder, the lowest effective doses of Risperdal are recommended. In cases of first symptoms of tardive dyskinesia, the antipsychotic application should be ceased, and the alternative treatment of the disease to be considered.
The information about psychotic disorders, contained in the review of Risperdal, is provided for informational purposes only, and should not be construed as a substitute for the professional advice, consultation or treatment of the professional trained psychiatrist. The online pharmacy will not be liable for any loss or damage of any nature, caused by improper use of information about antipsychotic agent Risperdal.
Risperdal Side Effects
The following adverse reactions may appear during application of Risperdal: dry mouth, headache, nasopharyngitis, fatigue, increased appetite, dystonia, rash, blurred vision, increased weight, parkinsonism, nasal congestion, and gastrointestinal disorders, including stomach discomfort, dyspepsia, upper abdominal pain or diarrhea.
The frequency of withdrawals of Risperdal treatment due to adverse reactions makes approximately 9%. The most common adverse reactions, which may result in the cessation of Risperdal therapy are: dizziness, psychosis, tachycardia, extrapyramidal disorder, vomiting, nausea, palpitations, akathisia, sleep disorders, hypotension, sedation.